Skip to main content

The Selective Cyclooxygenase-2-Inhibitor Rofecoxib may Improve the Treatment of Chronic Idiopathic Urticaria

Boehncke, W.-H., Ludwig, R.J., Zollner, T.M., Ochsendorf, F., Kaufmann, R., Gibbs, Bernhard F (2003) The Selective Cyclooxygenase-2-Inhibitor Rofecoxib may Improve the Treatment of Chronic Idiopathic Urticaria. British Journal of Dermatology, 148 (3). pp. 604-606. ISSN 0007-0963. (doi:10.1046/j.1365-2133.2003.05209_12.x) (The full text of this publication is not currently available from this repository. You may be able to access a copy if URLs are provided)

The full text of this publication is not currently available from this repository. You may be able to access a copy if URLs are provided. (Contact us about this Publication)
Official URL
http://dx.doi.org/10.1046/j.1365-2133.2003.05209_1...
Item Type: Article
DOI/Identification number: 10.1046/j.1365-2133.2003.05209_12.x
Subjects: R Medicine
Q Science > QR Microbiology > QR180 Immunology
Divisions: Faculties > Sciences > Medway School of Pharmacy
Depositing User: Bernhard F. Gibbs
Date Deposited: 05 Sep 2008 12:40 UTC
Last Modified: 28 May 2019 13:40 UTC
Resource URI: https://kar.kent.ac.uk/id/eprint/4812 (The current URI for this page, for reference purposes)
  • Depositors only (login required):